Latest 10-K annual reports
NASDAQ
AeroVironment, a leading defense technology provider, reported a 14% revenue increase to $820.6 million for fiscal year 2025, driven by strong demand for loitering munitions, while completing the transformative $2.64 billion BlueHalo acquisition and significantly growing its funded backlog to $726.6 million.
NASDAQ
ATEX
Anterix INC10-K: Anterix Reports Increased Net Loss Amidst Strategic Review and Key Spectrum Commercialization Gains
Anterix Inc. reported an increased net loss for fiscal year 2025, driven by strategic investments and severance costs, while simultaneously advancing its 900 MHz spectrum commercialization with new customer agreements and significant regulatory approvals.
OQB
Carver Bancorp, Inc. reported a net loss of $13.7 million for fiscal year 2025, a substantial increase from the prior year's $3.0 million loss, driven by higher interest expenses, increased non-interest expenses, and a rise in credit loss provisions, alongside a formal agreement with the OCC.
NASDAQ
Laser Photonics Corporation, a laser technology manufacturer, reported a net loss of $2.52 million and a substantial decrease in cash to $0.53 million in 2024, despite strategic acquisitions and efforts to expand its market reach, while also disclosing material weaknesses in its internal controls.
OQB
Spectral Capital Corporation, a deep quantum technology platform company, reported a significant increase in net losses to $3.27 million in 2024 with no revenue, raising substantial doubt about its ability to continue as a going concern without immediate capital infusion.
OID
SPTY
Specificity, INCSpecificity, Inc.'s 2024 annual report reveals a net loss of $615,261 and a worsening working capital deficit, raising substantial doubt about its ability to continue as a going concern, despite efforts to streamline operations and secure new financing.
NYSE
C3.ai, Inc. announced a 25.3% increase in total revenue for fiscal year 2025, reaching $389.1 million, fueled by strong demand for its Enterprise AI solutions and strategic partnerships, even as the company continues to incur significant net losses.
NYSE
Ellington Credit Company has finalized its strategic shift from a residential mortgage REIT to a closed-end fund focused on corporate Collateralized Loan Obligations (CLOs), reporting a net loss of $7.9 million for the three-month period ended March 31, 2025, as it liquidates mortgage-related assets and expands its CLO portfolio.
NASDAQ
Casey's General Stores, Inc. announced robust financial results for fiscal year 2025, marked by significant revenue and profit growth, primarily fueled by its largest-ever acquisition and continued execution of its strategic expansion plan.
NASDAQ
Israel Acquisitions Corp has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, primarily to include its previously omitted executive Clawback Policy and updated certifications.
NASDAQ
Grace Therapeutics, Inc. announced positive Phase 3 clinical trial results for its lead drug candidate, GTx-104, and plans for an FDA New Drug Application submission in the first half of calendar year 2025, despite reporting continued operating losses and a need for additional capital.
OTC.Pink
Blue Star Foods Corp. reported a significant increase in net loss and a sharp decline in revenue for the fiscal year ended December 31, 2024, raising substantial doubt about its ability to continue as a going concern, compounded by its recent delisting from Nasdaq.
OID
Farmhouse Inc. reported a net loss of $464,343 for 2024, continuing its financial struggles while pivoting from Web3 to a casual lifestyle brand holding company through planned acquisitions.
NASDAQ
AHCO
Adapthealth CORPAdaptHealth Corp. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, solely to include the previously omitted Equity Compensation Plan Table.
OTC.Pink
Pacific Green Technologies Inc. reported a net profit for fiscal year 2024 driven by significant BESS project sales and revenue growth, despite disclosing material weaknesses in internal financial controls and substantial doubt about its ability to continue as a going concern.
NASDAQ
NCRA
Nocera, INCNocera, Inc. has filed an amended annual report for fiscal year 2024, restating its interim financial statements due to errors in warrant liability valuation and asset misclassifications, while reporting a significant decline in net sales and ongoing concerns about its ability to continue as a going concern.
NASDAQ
Rocky Mountain Chocolate Factory, Inc. reported a significant increase in net loss and negative cash flow for fiscal year 2025, prompting its auditor to raise substantial doubt about the company's ability to continue as a going concern, despite recent capital raises and debt covenant waivers.
NASDAQ
Daktronics, Inc. filed an Amendment No. 1 to its Annual Report on Form 10-K to correct an administrative error regarding its auditor's consent and to include updated certifications from its principal executive and financial officers.
OID
CYAN
Cyanotech CORPCyanotech Corporation announced a 5% increase in net sales and a significant reduction in operating and net losses for fiscal year 2025, despite auditors raising substantial doubt about the company's ability to continue as a going concern.
OTC.Pink
CBGGF
Chain Bridge IChain Bridge I, a blank check company, reported a net loss for 2024, a significant working capital deficit, and the termination of its proposed business combination with Phytanix Bio, leading to its delisting from Nasdaq and raising substantial doubt about its ability to continue as a going concern.
NASDAQ
XAIR
Beyond Air, INCBeyond Air, Inc. reported a net loss of $48.5 million for the fiscal year ended March 31, 2025, with its independent auditors expressing substantial doubt about the company's ability to continue as a going concern despite increased revenue from its LungFit PH system and ongoing capital raising efforts.
NYSE
Medtronic plc reported a 4% increase in net sales and a significant rise in GAAP net income for fiscal year 2025, fueled by strong performance in its Cardiovascular, Neuroscience, and Diabetes segments, while also announcing plans to separate its Diabetes business.
NASDAQ
Smith & Wesson Brands, Inc. announced a substantial decrease in net sales and net income for fiscal year 2025, driven by lower consumer demand and increased operational costs, while navigating a complex legal and regulatory landscape.
NASDAQ
Modular Medical, Inc., a pre-revenue medical device company, has received FDA clearance for its MODD1 insulin pump and plans initial shipments by September 2025, while acknowledging substantial doubt about its ability to continue as a going concern without further capital.
NYSE
ORCL
Oracle CORPOracle Corporation announced robust revenue growth driven by its cloud services in fiscal year 2025, alongside significant capital expenditures for infrastructure expansion and ongoing strategic investments in AI, despite reporting negative free cash flow.
NYSE
The J. M. Smucker Company recorded a significant net loss of $1.23 billion in fiscal year 2025, primarily due to substantial goodwill and intangible asset impairment charges related to its Hostess Brands acquisition, despite a 7% increase in net sales.
NASDAQ
Borealis Foods Inc. has filed an Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, primarily to correct beneficial ownership information for directors, executive officers, and a significant shareholder.
NASDAQ
GSI Technology, a semiconductor memory solutions provider, reported a significantly reduced net loss for fiscal year 2025, driven by cost-cutting measures and a one-time gain from a property sale, while actively pursuing strategic alternatives and advancing its AI-focused Associative Processing Unit technology.
GMS
Gms INCGMS Inc. announced a substantial 58.2% decrease in net income and an 18.6% drop in Adjusted EBITDA for fiscal year 2025, primarily due to softening market demand, deflationary pricing in steel framing, and a $42.5 million goodwill impairment charge, despite a slight increase in net sales driven by strategic acquisitions.
OTC.Pink
10-K/A: Vocodia Holdings Corp Restates 2024 Financials Amidst Significant Losses and Going Concern Doubts
Vocodia Holdings Corp has filed an amendment to its 2024 annual report, restating financial statements due to a misclassified transaction, revealing increased net losses and raising substantial doubt about its ability to continue as a going concern.